AesThera Corporation – Trademark Portfolio
Entity Type: 03
AesThera Corporation holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include ISOLAZ. The owner is based in Hayward, CA.
c/o Solta Medical, Inc.
25881 Industrial Boulevard
Hayward, CA 94545
Showing of trademarks Trademarks
Trademark Classifications
AesThera Corporation's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does AesThera Corporation have?
AesThera Corporation has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 5 cancelled.
What trademark classes does AesThera Corporation file in?
AesThera Corporation files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 44 (Medical Services), Class 3 (Cosmetics & Cleaning). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are AesThera Corporation's most well-known trademarks?
AesThera Corporation's registered trademark portfolio includes well-known marks such as ISOLAZ. These are among 1 currently registered trademark in the portfolio.
What is AesThera Corporation's trademark registration success rate?
AesThera Corporation has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 1 application is pending review.